Produção Nacional
Revisado por pares
Identification of the TP53 p.R337H Variant in Tumor Genomic Profiling Should Prompt Consideration of Germline Testing for Li-Fraumeni Syndrome
2021; Lippincott Williams & Wilkins; Issue: 7 Linguagem: Inglês
10.1200/go.21.00097
ISSN2687-8941
AutoresRenata Lazari Sandoval, Cibele Masotti, Mariana Petaccia de Macêdo, Maurício Fernando Silva Almeida Ribeiro, Ana Carolina Rathsam Leite, Sibele I. Meireles, Rodrigo Medeiros Bovolin, Fernando C. Santini, Rodrigo Ramella Munhoz, Denis L. Jardim, Artur Katz, Anamaria A. Camargo, Gustavo dos Santos Fernandes, Maria Isabel Achatz,
Tópico(s)Cancer Genomics and Diagnostics
ResumoLi-Fraumeni syndrome (LFS) is rare in the worldwide population, but it is highly prevalent in the Brazilian population because of a founder mutation,
Referência(s)